Document type

Article

Version

Published version

Publication date

Publication license

cc by-nc (c) Vacas Córdoba et al., 2017
Please use this identifier to cite or link to this item: https://hdl.handle.net/2445/145140

Empirical treatment of adults with hospital-acquired pneumonia: lights and shadows of the 2016 Clinical Practice ATS/IDSA Guidelines

Journal Title

Director/Tutor

Journal ISSN

Volume Title

Abstract

Hospital-acquired pneumonia (HAP) is a common cause of nosocomial infection associated with significant morbidity and mortality. New clinical practice guidelines for the management of adults with hospital-acquired pneumonia have been published in 2016 by the Infectious Diseases Society of America (IDSA) and the American Thoracic Society (ATS). This review focuses on the recent recommendations and their limitations. We also focus on new therapeutic options that might improve the treatment and outcomes of these patients.

Citation

Citation

VACAS CÓRDOBA, Miguel, et al. Empirical treatment of adults with hospital-acquired pneumonia: lights and shadows of the 2016 Clinical Practice ATS/IDSA Guidelines. Revista Española de Quimioterapia. 2017. Vol. 30-33. ISSN 0214-3429. [consulted: 6 of June of 2026]. Available at: https://hdl.handle.net/2445/145140

Export metadata

JSON - METS

Share record